NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 863 coverGALANIN: BASIC RESEARCH DISCOVERIES AND THERAPEUTIC IMPLICATIONS Copyright © 1998 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by BRANCHEK, T.
Articles by WALKER, M. W.
Search for Related Content
PubMed
PubMed Citation
Articles by BRANCHEK, T.
Articles by WALKER, M. W.
Annals of the New York Academy of Sciences 863:94-107 (1998)
© 1998 New York Academy of Sciences

Molecular Biology and Pharmacology of Galanin Receptors

THERESA BRANCHEKa, KELLI E. SMITH AND MARY W. WALKER

Synaptic Pharmaceutical Corporation, 215 College Road, Paramus, New Jersey 07652, USA

aCorresponding author. Phone, 201-261-1331 ext 118; fax, 201-261-0623; e-mail, tabranchek{at}synapticcorp.com

Galanin was first isolated 15 years ago. Diversity of galanin receptors has been suspected from the study of native tissues and functional responses to galanin and galanin-like peptides in vitro and in vivo. The recent application of molecular biologic techniques to clone galanin receptors has extended this diversity. So far, three galanin receptor subtypes, GALR1, GALR2, and GALR3, have been cloned from both human and rat. Their molecular structure, pharmacologic profiles, tissue distribution, and signal transduction properties have been partially elucidated.




This article has been cited by other articles:


Home page
J. Physiol.Home page
A. J. Page, J. A. Slattery, S. M. Brierley, A. S. Jacoby, and L. A. Blackshaw
Involvement of galanin receptors 1 and 2 in the modulation of mouse vagal afferent mechanosensitivity
J. Physiol., September 1, 2007; 583(2): 675 - 684.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. G. Kozoriz, J. B. Kuzmiski, M. Hirasawa, and Q. J. Pittman
Galanin Modulates Neuronal and Synaptic Properties in the Rat Supraoptic Nucleus in a Use and State Dependent Manner
J Neurophysiol, July 1, 2006; 96(1): 154 - 164.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Kuramochi, T. Onaka, D. Kohno, S. Kato, and T. Yada
Galanin-Like Peptide Stimulates Food Intake via Activation of Neuropeptide Y Neurons in the Hypothalamic Dorsomedial Nucleus of the Rat
Endocrinology, April 1, 2006; 147(4): 1744 - 1752.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. L. Gottsch, H. Zeng, J. G. Hohmann, D. Weinshenker, D. K Clifton, and R. A. Steiner
Phenotypic Analysis of Mice Deficient in the Type 2 Galanin Receptor (GALR2)
Mol. Cell. Biol., June 1, 2005; 25(11): 4804 - 4811.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. Schauble, K. Reichwald, W. Grassl, H. Bechstein, H.-C. Muller, A. Scherag, F. Geller, M. Utting, W. Siegfried, H. Goldschmidt, et al.
Human Galanin (GAL) and Galanin 1 Receptor (GALR1) Variations Are Not Involved in Fat Intake and Early Onset Obesity
J. Nutr., June 1, 2005; 135(6): 1387 - 1392.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Bartfai, X. Lu, H. Badie-Mahdavi, A. M. Barr, A. Mazarati, X.-Y. Hua, T. Yaksh, G. Haberhauer, S. C. Ceide, L. Trembleau, et al.
Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests
PNAS, July 13, 2004; 101(28): 10470 - 10475.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z.-Q. D. Xu, X. Ma, U. Soomets, U. Langel, and T. Hokfelt
Electrophysiological evidence for a hyperpolarizing, galanin (1-15)-selective receptor on hippocampal CA3 pyramidal neurons
PNAS, December 7, 1999; 96(25): 14583 - 14587.
[Abstract] [Full Text] [PDF]



footerLeft footerRight